ANDA Challenges To Formulation Patents May Get Easier After KSR Ruling

The pharmaceutical industry could have a tougher time protecting certain drug patents - particularly those in ANDA litigation - following a U.S. Supreme Court decision that expands the situations under which an invention can be considered obvious